{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:11:37Z","timestamp":1648959097729},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Klin."],"published-print":{"date-parts":[[1997,7]]},"DOI":"10.1007\/bf03042576","type":"journal-article","created":{"date-parts":[[2009,5,30]],"date-time":"2009-05-30T01:58:17Z","timestamp":1243648697000},"page":"432-438","source":"Crossref","is-referenced-by-count":2,"title":["Zytokine und Herzkrankheiten"],"prefix":"10.1007","volume":"92","author":[{"given":"Karl","family":"Werdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03042576_CR1","first-page":"709","volume":"139","author":"E. Arbustini","year":"1991","unstructured":"Arbustini, E., M. Grasso, M. Diegoli, M. Bramerio, A. S. Foglieni, M. Albertario, L. Martinelli, A. Gavazzi, C. Goggi, C. Campana, M. Vigano: Expression of tumor necrosis factor in human acute cardiac rejection. Amer. J. Path. 139 (1991), 709\u2013715.","journal-title":"Amer. J. Path."},{"key":"BF03042576_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00024382-199404000-00001","volume":"1","author":"P. Boekstegers","year":"1994","unstructured":"Boekstegers, P., S. Weidenh\u00f6fer, R. Zell, G. Pilz, E. Holler, W. Ertel, T. Kapsner, H. Redl, G. Schlag, M. Kaul, K. Kempeni, R. Stenzel, K. Werdan: Repeated administration of a F(ab\u2019), fragment of an anti-tumor necrosis factor \u03b1 monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levels. Shock 1 (1994), 237\u2013245.","journal-title":"Shock"},{"key":"BF03042576_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00426336","volume":"156","author":"P. Boekstegers","year":"1996","unstructured":"Boekstegers, P., I. Kainz, W. Giehrl, W. Peter, K. Werdan: Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor \u03b1 attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations. Mol. Cell. Biochem. 156 (1996), 135\u2013143.","journal-title":"Mol. Cell. Biochem."},{"key":"BF03042576_CR4","first-page":"283","volume":"22","author":"S. Chollet-Martin","year":"1990","unstructured":"Chollet-Martin, S., J. P. Depoix, U. Hvass, Y. Pansard, C. Vissuzaine, M. A. Gougerot-Pocidalo: Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant. Proc. 22 (1990), 283\u2013286.","journal-title":"Transplant. Proc."},{"issue":"Suppl. 4","key":"BF03042576_CR5","first-page":"109","volume":"23","author":"P. Fraunberger","year":"1996","unstructured":"Fraunberger, P., A. K. Walli, D. Seidel: Stellenwert von Zytokinen in der Sepsis-Diagnostik. Infusionsther. Transfusionsmed. 23, Suppl. 4 (1996), 109\u2013116.","journal-title":"Infusionsther. Transfusionsmed"},{"key":"BF03042576_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/978-3-642-60463-8_5","volume-title":"The role of immune mechanisms in cardiovascular disease","author":"P. Liu","year":"1997","unstructured":"Liu, P.: The role of cytokines in the pathogenesis of myocarditis. In: Schulthei\u00df, H.-P., P. Schwimmbeck: The role of immune mechanisms in cardiovascular disease. Springer, Berlin-Heidelberg-New York 1997, p. 44\u201356."},{"issue":"Suppl. 4","key":"BF03042576_CR7","first-page":"35","volume":"23","author":"B. Maisch","year":"1996","unstructured":"Maisch, B., M. Herzum, G. Hufnagel, U. Sch\u00f6nian, A. Richter, M. Herzum, G. Hufnagel, U. Sch\u00f6nian, A. Richter, M. Ritter, V. Ruppert, Ch. Bethge, S. Pankuweit: Mechanismen immunologisch vermittelter kardialer Funktionsst\u00f6rung bei Myokarditis und dilatativer Kardiomyopathie. Infusionsther. Transfusionsmed. 23, Suppl. 4 (1996), 35\u201350.","journal-title":"Transfusionsmed"},{"key":"BF03042576_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/hrt.72.6.561","volume":"72","author":"A. Matsumori","year":"1994","unstructured":"Matsumori, A., T. Yamada, H. Suzuki, Y. Matoba, S. Sasayama: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Brit. Heart J. 72 (1994), 561\u2013566.","journal-title":"Brit. Heart J."},{"key":"BF03042576_CR9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00001573-199605000-00011","volume":"11","author":"A. Matsumori","year":"1996","unstructured":"Matsumori, A.: Cytokines in myocarditis and cardiomyopathies. Curr. Opin. Cardiol. 11 (1996), 302\u2013309.","journal-title":"Curr. Opin. Cardiol."},{"key":"BF03042576_CR10","first-page":"651","volume":"113","author":"C.P.J. Maury","year":"1989","unstructured":"Maury, C.P.J., E. Salo, P. Pelkonen: Elevated circulating tumor necrosis factor-\u03b1 in patients with Kawasaki disease. J. Lab. clin. Med. 113 (1989), 651\u2013654.","journal-title":"J. Lab. clin. Med."},{"key":"BF03042576_CR11","first-page":"215","volume-title":"Cytokines and the heart \u2014 Molecular mechanisms of septic cardiomyopathy","author":"U. M\u00fcller-Werdan","year":"1996","unstructured":"M\u00fcller-Werdan, U., C. Reithmann, K. Werdan: Cytokines in non-septic heart diseases. In: M\u00fcller-Werdan, U., C. Reithmann, K. Werdan: Cytokines and the heart \u2014 Molecular mechanisms of septic cardiomyopathy. Landes, Georgetown USA\/Chapman & Hall, New York USA\/Springer, Heidelberg 1996, 215\u2013233."},{"issue":"Suppl. 1","key":"BF03042576_CR12","first-page":"3","volume":"109","author":"U. M\u00fcller-Werdan","year":"1997","unstructured":"M\u00fcller-Werdan, U., R. Prondzinsky, R. Witthaut, N. Stache, K. Heinroth, C. Kuhn, H. Schmidt, I. Busch, K. Werdan: Das Herz bei Sepsis und MODS. Wien. klin. Wschr. 109, Suppl. 1 (1997) 3\u201324.","journal-title":"Wien. klin. Wschr."},{"issue":"Suppl. 4","key":"BF03042576_CR13","first-page":"22","volume":"23","author":"H. Neuhof","year":"1996","unstructured":"Neuhof, H., R. Soeparwata, C. Neuhof, H. H. Scheld: Zur pathophysiologischen Rolle von Zytokinen beim kardiopulmonalen Bypass. Infusionsther. Transfurions-medizin 23, Suppl. 4 (1996), 22\u201328.","journal-title":"Transfurions-medizin"},{"key":"BF03042576_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.me.40.020189.002345","volume":"40","author":"J. E. Parrillo","year":"1989","unstructured":"Parrillo, J. E.: The cardiovascular pathophysiology of sepsis. Ann. Rev. Med. 40 (1989), 469\u2013485.","journal-title":"Ann. Rev. Med."},{"key":"BF03042576_CR15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM199305203282008","volume":"328","author":"J. E. Parrillo","year":"1993","unstructured":"Parrillo, J. E.: Pathogenetic mechanisms of septic shock. New Engl. J. Med. 328 (1993), 1471\u20131477.","journal-title":"New Engl. J. Med."},{"key":"BF03042576_CR16","first-page":"174","volume":"42","author":"G. Pilz","year":"1994","unstructured":"Pilz, G., P. McGinn, P. Boekstegers, S. K\u00e4\u00e4b, S. Weidenh\u00f6fer, K. Werdan: Pseudomonas sepsis does not cause more severe cardiovascular dysfunction in patients than non-Pseudomonas sepsis. Circulat. Shock 42 (1994). 174\u2013182.","journal-title":"Circulat. Shock"},{"issue":"Suppl. 4","key":"BF03042576_CR17","first-page":"29","volume":"23","author":"G. Pilz","year":"1996","unstructured":"Pilz, G., P. Fraunberger, R. Appel, E. Kreuzer, K. Werdan, A. Walli, D. Seidel: Bedeutung erh\u00f6hter TNF-Rezeptorspiegel bei herzchirurgischen Risikopatienten. Infusionsther. Transfusionsmed. 23, Suppl. 4 (1996), 29\u201334.","journal-title":"Transfusionsmed"},{"key":"BF03042576_CR18","unstructured":"Prondzinsky, R., U. M\u00fcller-Werdan, G. Pilz, R. Witthaut, I. Stabenow, H.-R. Zerkowski, K. Werdan: Systemische Entz\u00fcndungsreaktion extrakorporaler Therapieverfahren (II): Der cardiopulmonale Bypass. Wien. klin. Wschr. (im Druck)."},{"key":"BF03042576_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0922-4106(91)90146-9","volume":"206","author":"C. Reithmann","year":"1991","unstructured":"Reithmann, C., P. Gierschik, K. Werdan, K. Jakobs: Tumor necrosis factor \u03b1 upregulates Gia and Gb proteins and adenylate cyclase responsiveness in rat cardiomyocytes. Europ. J. Pharmacol. Mol. Pharmacol. Sect. 206 (1991), 53\u201360.","journal-title":"Europ. J. Pharmacol. Mol. Pharmacol. Sect."},{"key":"BF03042576_CR20","first-page":"175","volume":"349","author":"C. Reithmann","year":"1994","unstructured":"Reithmann, C., K. Werdan: Tumor necrosis factor \u03b1 decreases inositol phosphate formation and phosphati-dylinositol-bisphosphate (PIP2) synthesis in rat cardiomyocytes. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 349 (1994), 175\u2013182.","journal-title":"Pharmacol"},{"key":"BF03042576_CR21","unstructured":"Schuster, H. P.: VI. Schlu\u00dffolgerungen. In: Werdan, K., H.-P. Schuster, G. Schlag, G. Spilker, R. Neumann: Sepsis: Toxinwirkung, Herzsch\u00e4digung, Quantifizierung, supportive Therapie mit Immunglobulinen. Intensivmedizin 26, Suppl. 1 (1989), 152\u2013153."},{"key":"BF03042576_CR22","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-07958-4","volume-title":"Intensivtherapie bei Sepsis und Multiorganversagen","author":"H.-P. Schuster","year":"1996","unstructured":"Schuster, H.-P.: Intensivtherapie bei Sepsis und Multiorganversagen, 2. Aufl. Springer, Berlin-Heidelberg-New York 1996.","edition":"2. Aufl."},{"key":"BF03042576_CR23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","volume":"27","author":"C. Torre-Amione","year":"1996","unstructured":"Torre-Amione, C., S. Kapadia, C. Benedict, H. Oral, J. B. Young, D. L. Mann: Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J. Amer. Coll. Cardiol. 27 (1996), 1201\u20131206.","journal-title":"J. Amer. Coll. Cardiol."},{"issue":"Suppl. 2","key":"BF03042576_CR24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2036.1996.22164021.x","volume":"10","author":"M. L.-S. Tsang","year":"1996","unstructured":"Tsang, M. L.-S., J. A. Weatherbee: Cytokine assays and their limitations. Aliment. Pharmacol. Ther. 10, Suppl. 2 (1996), 55\u201361.","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BF03042576_CR25","first-page":"269","volume":"63","author":"S. Wan","year":"1996","unstructured":"Wan, S., J.-L. LeClerc, J.-L. Vincent: Cytokine response to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann. thorac. Surg. 63 (1996), 269\u2013276.","journal-title":"Ann. thorac. Surg."},{"key":"BF03042576_CR26","first-page":"526","volume":"86","author":"K. Werdan","year":"1991","unstructured":"Werdan, K., P. Boekstegers, U. M\u00fcller, A. Pfeifer, G. Pilz, C. Reithmann, S. Hallstr\u00f6m, B. Koidl, H.P. Schuster, G. Schlag: Akute septische Kardiomyopathie: Bestandteil des Multiorganversagens in der Sepsis? Med. Klin. 86 (1991), 526\u2013534.","journal-title":"Med. Klin."},{"key":"BF03042576_CR27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/978-3-642-79154-3_43","volume-title":"Yearbook of intensive care and emergency medicine","author":"K. Werdan","year":"1995","unstructured":"Werdan, K.: Towards a more causal treatment of septic cardiomyopathy. In: Vincent, J.-L.: Yearbook of intensive care and emergency medicine. Springer Berlin-Heidelberg-New York-Tokyo 1995, 518\u2013538."},{"key":"BF03042576_CR28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00408670","volume":"163\/164","author":"K. Werdan","year":"1996","unstructured":"Werdan, K., U. M\u00fcller-Werdan: Elucidating molecular mechanisms of septic cardiomyopathy \u2014 the cardiomyocyte model. Mol. Cell. Biochem. 163\/164 (1996), 291\u2013303.","journal-title":"Mol. Cell. Biochem."},{"key":"BF03042576_CR29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00003246-199605000-00007","volume":"24","author":"J. H. Zwaveling","year":"1996","unstructured":"Zwaveling, J. H., J. K. Maring, F. L. Clarke, R. J. van Ginkel, P. C. Limburg, H. J. Hoekstra, H. S. Koops, A. R. J. Girbes: High plasma tumor necrosis factor (TNF)-\u03b1 concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-\u03b1, interferon-\u03c8, and melphalan. Crit. Care Med. 24 (1996), 765\u2013770.","journal-title":"Crit. Care Med."}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03042576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03042576\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03042576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:38:17Z","timestamp":1558481897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03042576"}},"subtitle":["Versuch einer Standortbestimmung"],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["BF03042576"],"URL":"https:\/\/doi.org\/10.1007\/bf03042576","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"value":"0723-5003","type":"print"},{"value":"1615-6722","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}